- Home
- ORIC vs STKL Comparison
ORIC vs STKL Comparison
Compare ORIC & STKL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORIC
- STKL
- Stock Information
- Founded
- ORIC 2014
- STKL 1973
- Country
- ORIC United States
- STKL United States
- Employees
- ORIC N/A
- STKL N/A
- Industry
- ORIC Biotechnology: Pharmaceutical Preparations
- STKL Precious Metals
- Sector
- ORIC Health Care
- STKL Basic Materials
- Exchange
- ORIC Nasdaq
- STKL Nasdaq
- Market Cap
- ORIC 545.5M
- STKL 631.4M
- IPO Year
- ORIC 2020
- STKL N/A
- Fundamental
- Price
- ORIC $5.61
- STKL $4.86
- Analyst Decision
- ORIC Strong Buy
- STKL Strong Buy
- Analyst Count
- ORIC 9
- STKL 2
- Target Price
- ORIC $18.43
- STKL $9.50
- AVG Volume (30 Days)
- ORIC 672.2K
- STKL 758.4K
- Earning Date
- ORIC 05-05-2025
- STKL 05-07-2025
- Dividend Yield
- ORIC N/A
- STKL N/A
- EPS Growth
- ORIC N/A
- STKL N/A
- EPS
- ORIC N/A
- STKL N/A
- Revenue
- ORIC N/A
- STKL $723,728,000.00
- Revenue This Year
- ORIC N/A
- STKL $9.79
- Revenue Next Year
- ORIC N/A
- STKL $7.58
- P/E Ratio
- ORIC N/A
- STKL N/A
- Revenue Growth
- ORIC N/A
- STKL 15.48
- 52 Week Low
- ORIC $5.53
- STKL $4.77
- 52 Week High
- ORIC $14.67
- STKL $8.11
- Technical
- Relative Strength Index (RSI)
- ORIC 30.76
- STKL 22.26
- Support Level
- ORIC $5.78
- STKL $5.08
- Resistance Level
- ORIC $8.11
- STKL $5.10
- Average True Range (ATR)
- ORIC 0.52
- STKL 0.18
- MACD
- ORIC -0.13
- STKL 0.00
- Stochastic Oscillator
- ORIC 1.59
- STKL 8.82
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
About STKL SunOpta Inc.
SunOpta Inc is a Canadian company that focuses on a healthy product portfolio. The company is a manufacturer for leading natural and private label brands and also produces its own propriety brands, including SOWN, Dream and West Life. The core of its product portfolio is a range of plant-based beverages, including oat, almond, soy, coconut and rice milks and creamers, which have a favorable climate profile relative to traditional dairy milks in terms of lower carbon emissions and water usage. Their plant-based offerings include non-genetically modified, organic, and gluten-free products. The consumer products portfolio also includes protein shakes, teas, broths, and fruit snacks.